Search jobs 25-May-2021 Therapeutic Nuclear Medicines Market – Global Business Dynamics, Industry Opportunities, Risk And Driving Force 2028 | Bayer AG, Novartis AG, GE Healthcare, Curium Pharmaceuticals & so on…
According to a new market study by Future Market Insights (FMI), the global therapeutic nuclear medicines market will expand at a healthy rate between 2018 and 2028.
The growth of the market is majorly attributed to factors such as the growing acceptance rate of therapeutic nuclear medicines, also known as radiopharmaceuticals, among consumers and medical professionals. These medicines have proven to be largely free of negative side-effects and minimal risk factors.
Furthermore, the rising prevalence of prostate cancer is acting as a major growth attribute to the market. As the per statistics of the U.K. cancer research organization, prostate cancer is the most prevalent cancer among men with over 47,151 cases being d
International Isotopes Inc Announces 2020 Year End Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
International Isotopes Inc Announces 2020 Year End Financial Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
IDAHO FALLS, Idaho, Jan. 26, 2021 /PRNewswire/ International Isotopes Inc. (OTCQB: INIS) (the Company ) is pleased to announce the following developments.
International Isotopes recently signed a distribution agreement with a large American healthcare services company for its I-131 drug product for the treatment of disease of the thyroid and thyroid cancer. INIS expects to start distributing product to this company later in the first quarter and this should help to further expand sales of this important product in the U.S..
The Company was recently notified by the Department of Energy that it has been indemnified under the Price Anderson Act for a release of Cesium that occurred in May of 2019. The Company s field services unit, which has since been discontinued as the Company has focused on growing its healthcare related business segments, was removing an expended Cesium source from a blood irradiator unit, when the source was brea